YULIYA ALAYEVA: Open Payments
NPI 1255777850 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,219 in 30 payments from 8 companies in 2025. Trend: 2023 $705 · 2024 $979 · 2025 $1,219
Food & beverage: $1,219
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 14 | $380 |
| AOP Health US, LLC | 1 | $335 |
| AstraZeneca Pharmaceuticals LP | 4 | $201 |
| Alnylam Pharmaceuticals Inc. | 4 | $129 |
| Novartis Pharmaceuticals Corporation | 3 | $96 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| BridgeBio Pharma, Inc. | 1 | $29 |
| Medtronic, Inc. | 1 | $15 |
Products named: LifeVest, Rapiblyk, AMVUTTRA, ENTRESTO, FARXIGA, LEQVIO, Attruby, ELIQUIS.
Industry payments across NY — which companies pay providers there.
